Mar 08, 2018 21:05 pm UTC| Business
BASKING RIDGE, N.J., March 08, 2018 -- Caladrius Biosciences, Inc. (Nasdaq:CLBS) (“Caladrius” or the “Company”), a development-stage biopharmaceutical company with multiple technology platforms targeting autoimmune and...
Calithera Biosciences Reports Fourth Quarter 2017 Financial Results and Recent Highlights
Mar 08, 2018 21:05 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., March 08, 2018 -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical-stage pharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor...
AutoWeb Announces Executive Management Succession Process
Mar 08, 2018 21:04 pm UTC| Business
IRVINE, Calif., March 08, 2018 -- AutoWeb, Inc. (Nasdaq:AUTO), a pioneer and leading provider of digital automotive services connecting in-market car buyers with dealers and OEMs, has announced that the board of...
Yield10 Bioscience Announces Fourth Quarter and Full Year 2017 Financial Results
Mar 08, 2018 21:04 pm UTC| Business
WOBURN, Mass., March 08, 2018 -- Yield10 Bioscience, Inc. (NASDAQ:YTEN), a Company developing new technologies to achieve step-change improvements in crop yield to enhance global food security, today reported financial...
MyoKardia Reports Fourth Quarter and Full Year 2017 Financial Results
Mar 08, 2018 21:03 pm UTC| Business
Announced Achievement of Primary Endpoint and Additional Key Data from Low-Dose Mavacamten Cohort of PIONEER-HCM Phase 2 Study in Symptomatic, Obstructive Hypertrophic Cardiomyopathy Company to Host Conference Call and...
WHAT’S NEW IN THE ISLANDS OF THE BAHAMAS THIS SPRING
Mar 08, 2018 21:02 pm UTC| Business
Fort Lauderdale, Florida, March 08, 2018 -- The Islands Of The Bahamas are heating up this spring with seasonal deals, hotel updates and festivals worth traveling for. In a major development, the CDC reported there have...
Mar 08, 2018 21:02 pm UTC| Business
Met Primary Endpoint and Key Secondary Endpoints with Statistical Significance Study Results Inform Phase 3 EXPLORER-HCM Dosing; First Patient Planned for Q2 2018 Conference Call Today at 4:30 p.m. ET (1:30...